(Q44215564)

English

Comparison of current staging systems for advanced hepatocellular carcinoma not amendable to locoregional therapy as inclusion criteria for clinical trials

scientific article published on 27 December 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Comparison of current staging systems for advanced hepatocellular carcinoma not amendable to locoregional therapy as inclusion criteria for clinical trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

author name string

Xing Li

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Min Dong

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Qu Lin

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Zhan-Hong Chen

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Xiao-Kun Ma

5

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Yan-Fang Xing

6

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Xiang-Bo Wan

7

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Jing-Yun Wen

8

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Li Wei

9

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Jie Chen

10

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Xiang-Yuan Wu

11

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

publication date

27 December 2012

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Asia Pacific Journal of Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

86-92

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12050

21 January 2018

Sorafenib in advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12050

21 January 2018

Management of hepatocellular carcinoma: An update

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12050

21 January 2018

Design and endpoints of clinical trials in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12050

21 January 2018

A new prognostic score system in patients with advanced hepatocellular carcinoma not amendable to locoregional therapy: implication for patient selection in systemic therapy trials.

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12050

21 January 2018

Prognostic scores for hepatocellular carcinoma: none is the winner

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12050

21 January 2018

The challenge of prognosis and staging for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12050

21 January 2018

A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12050

21 January 2018

A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12050

21 January 2018

Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12050

21 January 2018

Prognostic value and clinical relevance of the 6th Edition 2002 American Joint Committee on Cancer staging system in patients with resectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12050

21 January 2018

A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12050

21 January 2018

A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12050

21 January 2018

Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients.

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12050

21 January 2018

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12050

21 January 2018

Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12050

21 January 2018

Prognosis of hepatocellular carcinoma: the BCLC staging classification

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12050

21 January 2018

The meaning and use of the area under a receiver operating characteristic (ROC) curve

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12050

21 January 2018

Measuring diagnostic and predictive accuracy in disease management: an introduction to receiver operating characteristic (ROC) analysis

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12050

21 January 2018

Prospective validation of the Chinese University Prognostic Index and comparison with other staging systems for hepatocellular carcinoma in an Asian population.

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12050

21 January 2018

Advanced hepatocellular carcinoma: which staging systems best predict prognosis?

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12050

21 January 2018

Validation of a new prognostic staging system for hepatocellular carcinoma: The JIS score compared with the CLIP score

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12050

21 January 2018

Identifiers

10.1111/AJCO.12050

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

release_3d7s32yq75d5pcnlctyz443fey

1 reference

https://api.fatcat.wiki/v0/release/3d7s32yq75d5pcnlctyz443fey

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44215564&oldid=2108620358"